KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Shares Issued (2016 - 2025)

LifeMD (LFMD) has disclosed Shares Issued for 11 consecutive years, with -$8.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 69831.71% year-over-year to -$8.7 million, compared with a TTM value of -$8.6 million through Dec 2025, down 7250.8%, and an annual FY2025 reading of $5950.0, down 95.05% over the prior year.
  • Shares Issued was -$8.7 million for Q4 2025 at LifeMD, down from $12499.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $12.7 million in Q4 2021 and bottomed at -$8.7 million in Q4 2025.
  • Average Shares Issued over 5 years is $884786.9, with a median of $38500.0 recorded in 2022.
  • The sharpest move saw Shares Issued skyrocketed 10317.9% in 2023, then plummeted 69831.71% in 2025.
  • Year by year, Shares Issued stood at $12.7 million in 2021, then crashed by 100.41% to -$51900.0 in 2022, then surged by 10317.9% to $5.3 million in 2023, then crashed by 99.76% to $12499.0 in 2024, then tumbled by 69831.71% to -$8.7 million in 2025.
  • Business Quant data shows Shares Issued for LFMD at -$8.7 million in Q4 2025, $12499.0 in Q4 2024, and $100000.0 in Q2 2024.